Evidence for bladder bactericidal factor
Perez, J.R.; Grieco, R.; Gillenwater, J.Y.
Investigative Urology 11(6): 489-495
1974
ISSN/ISBN: 0021-0005 PMID: 4597435 Document Number: 81619
Document emailed within 1 workday
Related Documents
Philippou, H.; Adami, A.; Lane, D.A.; MacGregor, I.R.; Tuddenham, E.G.; Lowe, G.D.; Rumley, A.; Ludlam, C.A. 1996: High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC Thrombosis and Haemostasis 76(1): 23-28Mokracka-Latajka, G.; Grzybek-Hryncewicz, K.; Jankowski, S. 1990: Sensitivity of Shigella strains to bactericidal activity of human serum. I. Participation of two independently active mechanisms in bactericidal action against Shigella sonnei phase II Acta Microbiologica Polonica 39(3-4): 111-116
Gianello, P.; Squifflet, J.P.; Carlier, M.; Jamart, J.; Pirson, Y.; Mahy, B.; Berbinschi, A.; Donckier, J.; Ketelslegers, J.M.; Lambotte, L. 1989: Evidence that atrial natriuretic factor is the humoral factor by which volume loading or mannitol infusion produces an improved renal function after acute ischemia. An experimental study in dogs Transplantation 48(1): 9-14
Löfgren, O. 2005: Women's "overactive" bladder--a not-evidence-based condition? Lakartidningen 102(42): 3060
Grosso, A.; Cox, J.A.; Malnoë, A.; de Sousa, R.C. 1982: Evidence for a role of calmodulin in the hydrosmotic action of vasopressin in toad bladder Journal de Physiologie 78(3): 270-278
Vecchioli-Scaldazza, C.; Grinta, R. 2010: Overactive bladder syndrome: what is the role of evidence of detrusor overactivity in the cystometric study? Minerva Urologica e Nefrologica 62(4): 355-361
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Mitnick, M.A.; Valverde, R.C.; Reichlin, S. 1973: Enzymatic synthesis of prolactin releasing factor prolactin releasing factor by rat hypothalamic incubates and by extracts of rat hypothalamic tissue evidence for prolactin releasing factor synthetase Proceedings of the Society for Experimental Biology and Medicine 143(2): 418-421
Bravo, P.; Del Rey Calero, J.; Sánchez, J.; Conde, M. 1987: Artificial sweeteners as a risk factor for cancer of the bladder Revista de Sanidad E Higiene Publica 61(3-4): 301-307
Keilholz, L. 1995: Is protein p53 an independent prognostic factor in bladder carcinoma? Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(9): 543-544
Cardillo, M.R.; Castagna, G.; Memeo, L.; De Bernardinis, E.; Di Silverio, F. 2000: Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer Journal of Experimental and Clinical Cancer Research: Cr 19(2): 225-233
Kanakura, Y.; Sugahara, H.; Mitsui, H.; Ikeda, H.; Furitsu, T.; Yagura, H.; Kitayama, H.; Kanayama, Y.; Matsuzawa, Y. 1993: Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor Cancer Research 53(3): 675-680
Belloso, L.; Zugasti, A.; Urkia, M.; Arozena, F.; Blasco-Olaetxea, E. 1997: The proliferating nuclear fraction as a prognostic factor in superficial bladder carcinomas Archivos Espanoles de Urologia 50(8): 831-836
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Salagovic, J.; Kalina, I.; Stubna, J.; Habalová, V.; Hrivnák, M.; Valanský, L.; Kohút, A.; Biros, E. 1998: Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers Neoplasma 45(5): 312-317
Satake, N.; Durham, J.H.; Brodsky, W.A. 1981: Reversal of the luminal acidification current by a phosphodiesterase inhibitor in the turtle bladder: evidence for active electrogenic biocarbonate secretion Progress in Clinical and Biological Research 73: 13-24
Onozaki, K.; Urawa, H.; Tamatani, T.; Iwamura, Y.; Hashimoto, T.; Baba, T.; Suzuki, H.; Yamada, M.; Yamamoto, S.; Oppenheim, J.J. 1988: Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor Journal of Immunology 140(1): 112-119
Xavier, R.M.; Nakamura, M.; Tsunematsu, T. 1994: Isolation and characterization of a human nonspecific suppressor factor from ascitic fluid of systemic lupus erythematosus. Evidence for a human counterpart of the monoclonal nonspecific suppressor factor and relationship to the T cell receptor alpha-chain Journal of Immunology 152(5): 2624-2632
Busto Castañón, L.; Sánchez Merino, J.M.; Picallo Sánchez, J.A.; Gelabert Mas, A. 2001: Expression of epidermal growth factor receptor and p53 protein in superficial cancer of the urinary bladder Archivos Espanoles de Urologia 54(1): 13-21
Chow, N.H.; Liu, H.S.; Lee, E.I.; Chang, C.J.; Chan, S.H.; Cheng, H.L.; Tzai, T.S.; Lin, J.S. 1997: Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer Anticancer Research 17(2b): 1293-1296